tiprankstipranks
Passage Bio (PASG)
NASDAQ:PASG
US Market

Passage Bio (PASG) Financial Statements

Compare
498 Followers

Passage Bio Financial Overview

Passage Bio's market cap is currently $32.00M. The company's EPS TTM is $-1.174; its P/E ratio is ―; Passage Bio is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -3.72M$ -3.68M$ -1.54M$ -800.00K$ -134.00K
Operating Income$ -108.39M$ -138.39M$ -185.73M$ -112.90M$ -37.19M
EBITDA$ -98.34M$ -138.39M$ -185.73M$ -112.90M$ -36.55M
Net Income$ -102.06M$ -136.86M$ -191.50M$ -111.76M$ -54.58M
Balance Sheet
Cash & Short-Term Investments$ 114.29M$ 189.61M$ 315.77M$ 304.82M$ 158.87M
Total Assets$ 150.54M$ 243.55M$ 355.08M$ 328.01M$ 178.61M
Total Debt$ 26.29M$ 27.11M$ 0.00$ 0.00$ 0.00
Net Debt$ 4.58M$ -7.49M$ -128.97M$ -135.00M$ -158.87M
Total Liabilities$ 39.26M$ 42.18M$ 36.42M$ 23.29M$ 4.26M
Stockholders' Equity$ 111.28M$ 201.37M$ 318.66M$ 304.71M$ 174.35M
Cash Flow
Free Cash Flow$ -78.41M$ -123.48M$ -152.52M$ -82.17M$ -41.59M
Operating Cash Flow$ -78.26M$ -118.21M$ -126.88M$ -80.52M$ -39.90M
Investing Cash Flow$ 65.24M$ 25.20M$ -45.81M$ -172.11M$ -1.69M
Financing Cash Flow$ 135.00K$ -1.35K$ 166.66K$ 228.75M$ 175.60M
Currency in USD

Passage Bio Earnings and Revenue History

Passage Bio Debt to Assets

Passage Bio Cash Flow

Passage Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis